These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21828944)

  • 21. A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime).
    Amoroso G; Vos NS; Van der Heyden JA; van der Schaaf RJ; Patterson MS; Vink MA; Herrman JP; Slagboom T
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S28-33. PubMed ID: 25754236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary stenting with MGuard: first-in-man trial.
    Kaluski E; Hauptmann KE; Müller R; Tsai S; Klapholz M; Grube E
    J Invasive Cardiol; 2008 Oct; 20(10):511-5. PubMed ID: 18829994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
    Vaknin-Assa H; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1055-7. PubMed ID: 19434749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes.
    Pasquetto G; Reimers B; Favero L; Saccà S; Cernetti C; Napodano M; Piccolo P; Pascotto P
    Ital Heart J; 2003 Sep; 4(9):614-9. PubMed ID: 14635379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real world comparison of the MGuard Stent versus the bare metal stent for ST elevation myocardial infarction (the REWARD-MI study).
    Fernández-Cisnal A; Cid-Álvarez B; Álvarez-Álvarez B; Cubero-Gómez JM; Ocaranza-Sánchez R; López-Otero D; Souto-Castro P; Díaz de la Llera LS; Trillo-Nouche R; González-Juanatey JR
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E1-9. PubMed ID: 24905554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MGuard coronary stent: safety, efficacy, and clinical utility.
    Gracida M; Romaguera R; Jacobi F; Gómez-Hospital JA; Cequier A
    Vasc Health Risk Manag; 2015; 11():533-9. PubMed ID: 26425097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent.
    Galli M; Bartorelli A; Bedogni F; DeCesare N; Klugmann S; Maiello L; Miccoli F; Moccetti T; Onofri M; Paolillo V; Pirisi R; Presbitero P; Sganzerla P; Viecca M; Zerboni S; Lanteri G
    J Invasive Cardiol; 2000 Sep; 12(9):452-8. PubMed ID: 10973369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could direct stenting reduce no-reflow in acute coronary syndromes? A randomized pilot study.
    Sabatier R; Hamon M; Zhao QM; Burzotta F; Lecluse E; Valette B; Grollier G
    Am Heart J; 2002 Jun; 143(6):1027-32. PubMed ID: 12075259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Secco GG; Serdoz R; Kilic ID; Caiazzo G; Mattesini A; Parisi R; De Luca G; Pistis G; Marino PN; Di Mario C
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):712-9. PubMed ID: 26541909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
    Lim SY; Park HW; Chung WY; Kim SY; Kim KS; Bae JW; Youn TJ;
    J Invasive Cardiol; 2012 Jun; 24(6):270-3. PubMed ID: 22684380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction.
    Dudek D; Dziewierz A; Kleczyński P; Giszterowicz D; Rakowski T; Sorysz D; Rzeszutko Ł; Legutko J; Bartuś S; Dragan J; Klecha A; Siudak Z; Żmudka K
    Kardiol Pol; 2014; 72(2):140-5. PubMed ID: 24142749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial).
    Dudek D; Brener SJ; Rakowski T; Dziewierz A; Abizaid A; Silber S; Yaacoby E; Dizon JM; Costa RA; Maehara A; Dressler O; Stone GW
    Am J Cardiol; 2014 Nov; 114(10):1485-9. PubMed ID: 25277335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of aortocoronary graft lesions with graft-stents.
    Boztosun B; Gunes Y; Olcay A; Esen AM; Esen OB; Saglam M; Kirma C
    Coron Artery Dis; 2006 May; 17(3):271-4. PubMed ID: 16728878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions.
    Weber F; Schneider H; Schwarz C; Holzhausen C; Petzsch M; Nienaber CA
    Z Kardiol; 2004 Dec; 93(12):938-43. PubMed ID: 15599568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
    Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
    EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.